AHCO · XBRL financial data

AdaptHealth financial statements, every fiscal year

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (AHCO's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	1,056	2,455	2,971	3,200	3,261	3,245
Cost of revenue	899	2,009	2,553	2,721	2,580	2,636
Cost of goods and services sold	899	2,009	2,553	2,721	2,580	2,636
General and administrative	89	168	162	190	359	382
Operating income (loss)	71	226	190	(598)	264	91
Interest expense	41	95	109	130	125	104
Other income (expense)	3	(2)	(0)	(30)	(3)	(0)
Income tax expense (benefit)	(12)	33	25	(49)	41	51
Net income (loss)	(162)	156	69	(679)	90	(71)
Earnings per share, basic USD per share	(3.08)	1.12	0.47	(5.06)	0.62	(0.52)
Earnings per share, diluted USD per share	(3.08)	0.67	0.33	(5.31)	0.61	(0.52)
Weighted average shares, basic millions of shares	52	126	134	134	134	135
Weighted average shares, diluted millions of shares	52	133	139	134	136	135

Fiscal years (AHCO's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	100	150	46	77	110	106
Accounts receivable	171	360	359	389	408	371
Inventory	59	123	128	114	140	151
Prepaid and other current assets	33	37	52	69	45	101
Total current assets	363	670	585	649	756	729
Property and equipment, net	110	399	—	495	475	503
Right-of-use asset	—	148	130	110	106	112
Goodwill	999	3,513	3,545	2,725	2,675	2,541
Total assets	1,813	5,250	5,220	4,509	4,487	4,317
Accounts payable	191	248	223	212	285	352
Current portion of long-term debt	8	20	35	53	16	20
Total current liabilities	422	500	456	537	567	712
Long-term debt	777	2,184	2,153	2,095	1,965	1,716
Lease liability, non-current	—	120	104	86	80	85
Total liabilities	1,533	3,184	3,062	3,042	2,909	2,790
Retained earnings (accumulated deficit)	(199)	(43)	26	(653)	(562)	(633)
Total stockholders' equity	355	2,062	2,151	1,458	1,571	1,519
Total liabilities and equity	1,813	5,250	5,220	4,509	4,487	4,317
Common shares outstanding (cover page) millions of shares	—	134	135	133	135	136

Fiscal years (AHCO's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(162)	156	69	(679)	90	(71)
Stock-based compensation	19	25	22	22	15	22
Depreciation and amortization	82	258	351	383	365	382
Net cash from operating activities	196	276	374	481	542	602
Purchases of property and equipment	40	203	391	337	306	382
Net cash from investing activities	(816)	(1,825)	(411)	(357)	(310)	(303)
Proceeds from issuing common stock	143	279	0	0	—	—
Share repurchases	0	0	14	29	0	0
Repayments of long-term debt	547	827	20	95	423	250
Net cash from financing activities	643	1,599	(66)	(93)	(199)	(302)
Net change in cash	23	50	(103)	31	33	(4)

SIC 8082 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8082 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
AdaptHealth	not reported	746	157*	136.5M	Q3 FY26 10-QSep 30, 2026
Addus HomeCare	100	377	40*	18.7M	Q2 FY26 10-QJun 30, 2026
Enhabit	50	265	35	51.2M	Q1 FY26 10-QMar 31, 2026
BrightSpring Health Services	718	4,213	204*	199.0M	Q3 FY26 10-QSep 30, 2026
Aveanna Healthcare Holdings	97	670	81*	218.2M	Q2 FY26 10-QJul 4, 2026

Not investment advice. Not affiliated with the U.S. SEC.